Clinical trial
Intravenous Versus Subcutaneous Administration of Low Molecular Weight Heparin for Thromboprophylaxis in Critically Ill Patients: a Randomized Controlled Trial
NCT04982055 is registered in ClinicalTrials.gov with Clinique Saint Pierre Ottignies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravenous Versus Subcutaneous Administration of Low Molecular Weight Heparin for Thromboprophylaxis in Critically Ill Patients: a Randomized Controlled Trial
- Lead sponsor
- Clinique Saint Pierre Ottignies
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 8, 2015
- Completion date
- December 31, 2020
- Enrollment
- 60 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.